MedTrace Logo

Clinical Feasibility Study of the BariTon™ System in Obese or Overweight Patients.

NCT06360679 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-04-11

No results posted yet for this study

Summary

Safety and efficacy evaluation of the BariTon™, BariaTek Medical gastric restriction and biliodigestive diversion device.

Conditions

Interventions

DEVICE

Endoscopic gastric restriction and biliodigestive diversion

The BariTon™ is endoscopically implanted and retrieved once treatment is completed

Sponsors & Collaborators

  • BariaTek Medical

    lead INDUSTRY

Principal Investigators

  • Adrian Sartoretto, Dr · The BMI Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-29
Primary Completion
2024-10-01
Completion
2025-06-01

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06360679 on ClinicalTrials.gov